Table 7.
Comparing inpatient medication management for patients with vaso-occlusive crisis in 2018 and 2019
| Inpatient Pain Medication | 2018 | 2019 | Difference(absolute) | P-value |
|---|---|---|---|---|
| Hydromorphone IV (%) | 95.7 | 72.7 | 23.0 | .034 |
| Hydromorphone PO (%) | 26.1 | 40.9 | 14.8 | .052 |
| Morphine IV (%) | 4.35 | 4.55 | 0.2 | .974 |
| Morphine PO (%) | 13.0 | 9.09 | 3.91 | .673 |
| Oxycodone PO (%) | 52.2 | 54.55 | 2.30 | .873 |
| Methadone (%) | 21.7 | 13.6 | 8.10 | .477 |
| Fentanyl IV (%) | 0 | 4.55 | 4.55 | .301 |
| Buprenorphine PO (%) | 0 | 4.55 | 4.55 | .301 |
| Ketamine IV (%) | 17.4 | 9.09 | 8.31 | .413 |
| Ketamine PO (%) | 0 | 22.73 | 22.7 | .015 |